Antibodies to extractable nuclear antigens (ENAS) in systemic lupus erythematosus patients: correlations with clinical manifestations and disease activity
Submitted: 3 June 2017
Accepted: 28 December 2017
Published: 6 July 2018
Accepted: 28 December 2017
Abstract Views: 2272
PDF: 1221
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- A.C.C.D. Baccaro, G.L. Behrens Pinto, R.C.S. Carboni, S.K. Shinjo, The clinical manifestations at the onset of antisynthetase syndrome: A chameleon with multiple faces , Reumatismo: Vol. 72 No. 2 (2020)
- E. Cárdenas-Cloud, A.J.L. Brambila-Tapia, R.M. Meda-Lara, F.d.J. Pérez-Vázquez, E. Chavarría-Ávila, F.J. Romero-Abundis, M. Vázquez-del-Mercado, Evaluation of a psychoeducational intervention including emotional intelligence to increase treatment adherence in rheumatoid arthritis (A pilot study) , Reumatismo: Vol. 73 No. 3 (2021)
- G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi, Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis , Reumatismo: Vol. 56 No. 2 (2004)
- M.E. Secchi, A. Sulli, C. Pizzorni, M. Cutolo, Nailfold capillaroscopy and blood flow laser-doppler analysis of the microvascular damage in systemic sclerosis: preliminary results , Reumatismo: Vol. 61 No. 1 (2009)
- A. Fassio, D. Gatti, P. Gisondi, G. Girolomoni, O. Viapiana, A. Giollo, M. Zamboni, M. Rossini, L. Idolazzi, Effects of secukinumab on serum adipocytokines: preliminary data , Reumatismo: Vol. 69 No. 3 (2017)
- G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone, Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE) , Reumatismo: Vol. 71 No. 1 (2019)
- M.S.M.S. Faria, S.K. Shinjo, COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis , Reumatismo: Vol. 74 No. 1 (2022)
- F.M. Mariani, A. Alunno, F. Carubbi, C. Ferri, A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib , Reumatismo: Vol. 76 No. 2 (2024)
- J.Ch Gerster, Amyloidoses as seen by the Rheumatologist , Reumatismo: Vol. 53 No. 3 (2001)
- B. Rothschild, Contributions of paleorheumatology to understanding contemporary disease , Reumatismo: Vol. 54 No. 3 (2002)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
You may also start an advanced similarity search for this article.